Net Cash Provided by (Used in) Financing Activities in USD of Immunovant, Inc. from 2018 to Q2 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Immunovant, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2018 to Q2 2025.
- Immunovant, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 30 Jun 2025 was $2.92M, a 325% increase year-over-year.
- Immunovant, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $454M, a 3.8% decline from 2023.
- Immunovant, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $472M, a 566% increase from 2022.
- Immunovant, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $70.9M, a 64.6% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)